CTOs on the Move

Ultracision

www.ultracision.com

 
Ultracision, Inc. is a Santa Clara, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Insitu Technologies Inc

Insitu Technologies Inc is a Saint Paul, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Value Drug Company

Value Drug Company, founded in 1934 and incorporated in 1936, is a wholesale purchasing cooperative of Independent Pharmacies.

Maui Youth & Family Services/Aloha House/Malama Family Recovery Center

Maui Behavioral Health Resources is an umbrella agency of three non-profit organizations that provide a continuum of care for more than 3,000 people and families a year affected by behavioral health issues.

axialHealthcare

axialHealthcare offers an evidence-driven, predictive solution that limits opioid misuse and optimizes care for patients with pain or opioid use disorder.

Relmada

Relmada Therapeutics (OTCQB: RLMD) is a clinical-stage, publicly traded specialty pharmaceutical company developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of chronic pain. Relmada has a diversified portfolio of four lead products at various stages of development including d-Methadone (REL-1017) its N-methyl-D-aspartate (NMDA) receptor antagonist for neuropathic pain; topical mepivacaine (REL-1021), its orphan drug designated topical formulation of the local anesthetic mepivacaine; oral buprenorphine (REL-1028) its oral dosage form of the opioid analgesic buprenorphine; and LevoCap ER (REL-1015), its abuse resistant, sustained release dosage form of the opioid analgesic levorphanol. Relmada`s product development efforts are guided by the internationally recognized scientific expertise of our research team. Relmada`s approach is expected to reduce clinical development risks and costs while potentially delivering valuable products in areas of high unmet medical needs.